Table 2.

Patient disposition at the time of data cutoff

Letrozole, n = 2,583
Placebo, n = 2,587
Total, n = 5,170
n (%)n (%)n (%)
No. patients treated2,567 (99.4)2,569 (99.3)5,136 (99.3)
    Treatment completed6 (0.2)8 (0.3)14 (0.3)
    Ongoing at time of data cutoff1,934 (74.9)1,884 (72.8)3,818 (73.8)
    Discontinued627 (24.3)677 (26.2)1,304 (25.2)
Reasons for treatment discontinuation
    Patient refusal303 (11.7)293 (11.3)596 (11.5)
    Toxicity of therapy127 (4.9)95 (3.7)222 (4.3)
    Other101 (3.9)136 (5.3)237 (4.6)
    Recurrent disease58 (2.2)109 (4.2)167 (3.2)
    Intercurrent illness22 (0.9)24 (0.9)46 (0.9)
    Death16 (0.6)18 (0.7)34 (0.7)
    Protocol violation0 (0.0)1 (0.0)1 (0.0)
    Unknown0 (0.0)1 (0.0)1 (0.0)